Exogenous ochronosis and striae atrophicae following the use of bleaching creams

International Journal of Dermatology

Volumn 44, Issue 2, 2005, Pages 112-115

  Bongiorno, Maria Rita ^a   Aricò, Mario ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; GLUCOCORTICOID; HEMATOXYLIN; HYDROQUINONE;

ACANTHOSIS; ADULT; AFRICA; ARTICLE; ATROPHIC SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; DERMIS; FACE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; LONG TERM CARE; NECK; OCHRONOSIS; SKIN BIOPSY; SKIN CARE; STRIA;

ATROPHY; DERMATOLOGIC AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROQUINONES; HYPERPIGMENTATION; MIDDLE AGED; OCHRONOSIS; SKIN;

EID: 14544300207     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02346.x     Document Type: Article

References (19)

1. Mahé A, Aymard FLG, Dangou JM. Skin disease associated with the cosmetic use of bleaching products in woman from Dakar. Senegal Br J Dermatol 2003; 3: 493-500.
2. Del Giudice P, Yves P. The widespread use of skin lightening creams in Senegal: a persistent public health problem in West Africa. Int J Dermatol 2002; 41: 69-74.
3. Pick L. Uber die Ochronoses Klin. Wochenschr 1906; 43: 478-480.
4. Phornphutkul C, Introne WJ, Perry MB, et al. Natural history of alkaptonuria. N Engl J Med 2002; 347: 2111-2121.
5. Hardwick N, Van Gelder LW, Van Der Merwe CA, et al. Exogenous ochronosis: an epidemiological study. Br J Dermatol 1989; 120: 229-238.
6. Kramer KE, Lopez A, Stefanato C, et al. Exogenous ochronosis. J Am Acad Dermatol 2000; 42: 869-871.
7. Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol 2001; 2: 213-217.
8. Cullison D, Abele DC, O'Quinn JL. Localized exogenous ochronosis: report a case and review of the literature. J Am Acad Dermatol 1983; 8: 882-889.
9. Snider RI, Thiers BH. Exogenous ochronosis. J Am Acad Dermatol 1993; 28: 662-664.
10. Dogliotte M, Liebowitz M. Granulomatous ochronosis-a cosmetic-induced skin disorder in blacks. S Afr Med J 1979; 56 757-760.
11. Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003; 16 101-110.
12. Penney KB, Smith Q, Allen JC. Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Invest Dermatol 1984; 82: 308-310.
13. Prota G. Melanins and Melanogenesis. New York: Academic Press, 1992: 1-290.
14. Haddad AL, Matos LF, Brunstein F, et al. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol 2003; 42: 153-156.
15. Karamagi C, Owinol E, Katabira ET. Hydroquinone neuropathy following use of skin bleaching creams: case report. East Afr Med J 2001; 78: 223-224.
16. De Caprio AP. The toxicology of hydroquinone-relevance to occupational and environmental exposure. Crit Rev Toxicol 1999; 29: 283-330.
17. Brauer EW. Safety of over-the counter hydroquonone bleaching creams. Arch Dermatol 1985; 121: 1239.
18. Keane FM, Munn SE, Taylor NF, et al. Unregulated use of clobetasol propionate. Br J Dermatol 2001; 144: 1095-1096.
19. Raynaud E, Cellier C, Perret JL. Depigmentation cutanée à visée cosmetique. Enquete de prevalence et effets indesiderables dans une population femmine senegalaise. Ann Dermatol Venereol 2001; 128: 720-724.